SCHD vs VYM: returns, risk and drawdowns compared
Schwab U.S. Dividend Equity ETF against Vanguard High Dividend Yield ETF, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
SCHD
Schwab U.S. Dividend Equity ETF
10,000 became
23,140
- A year on average
- +14.2%
- Annual volatility
- 15.7%
- Deepest fall
- −17.1%
- Worst month
- −8.6%
VYM
Vanguard High Dividend Yield ETF
10,000 became
24,293
- A year on average
- +15.0%
- Annual volatility
- 13.8%
- Deepest fall
- −14.1%
- Worst month
- −7.9%
VYM came out ahead by 0.9 percentage points a year from July 2020 to October 2026. SCHD swung more (15.7% against 13.8% a year). The correlation of monthly returns was 0.93: they moved almost in lockstep.
Growth of 10,000: SCHD vs VYM
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero SCHD had returned more, below zero VYM. SCHD was ahead in 0% of the 41 three-year periods.
Annualised 3-year return of SCHD minus that of VYM, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: SCHD −17.1%, VYM −14.1%.
All the figures
| SCHD | VYM | |
|---|---|---|
| Annual return (CAGR) | +14.2% | +15.0% |
| Total return | +131% | +143% |
| Annual volatility | 15.7% | 13.8% |
| Deepest fall (month-end) | −17.1% | −14.1% |
| Worst month | −8.6% | −7.9% |
| Best month | +13.2% | +12.3% |
| Positive months | 59% | 61% |
| Best year | 2021: +27.3% | 2021: +26.2% |
| Worst year | 2022: −5.5% | 2022: −0.4% |
| 1-year return | +37.2% | +16.6% |
| 5 years, a year | +8.5% | +11.3% |
| 10 years, a year | +11.5% | — |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half SCHD, half VYM
| SCHD alone | VYM alone | 50/50 | |
|---|---|---|---|
| A year on average | +14.2% | +15.0% | +14.6% |
| Annual volatility | 15.7% | 13.8% | 14.5% |
| Deepest fall (month-end) | −17.1% | −14.1% | −15.3% |
| Worst month | −8.6% | −7.9% | −8.2% |
With a correlation of 0.93 the mix behaved almost like either fund alone: its volatility of 14.5% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, SCHD or VYM?
From July 2020 to October 2026, SCHD returned +14.2% a year and VYM +15.0% a year, with dividends reinvested. Over rolling 3-year periods SCHD did better in 0% of cases. Past returns do not predict future returns.
Which is riskier, SCHD or VYM?
Over the same months annual volatility was 15.7% for SCHD and 13.8% for VYM; the deepest fall from a month-end high was 17.1% and 14.1%, and the worst single month −8.6% and −7.9%.
How correlated are SCHD and VYM?
The correlation of their monthly returns was 0.93: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both SCHD and VYM?
Half in each, rebalanced every month, returned +14.6% a year over the same period, with 14.5% annual volatility and a deepest month-end fall of 15.3%.
More comparisons
- SCHD — Schwab U.S. Dividend Equity ETFReturns, drawdowns and risk
- VYM — Vanguard High Dividend Yield ETFReturns, drawdowns and risk
- SCHD vs VIG
- SCHD vs DGRO
- VOO vs SCHD
- SCHD vs JEPI
- VYM vs VIG
- VYM vs DGRO
- Backtest a portfolio on past crisesRebalancing, costs and attribution
- Portfolio Visualizer alternativesWhich tool fits which job
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.